Close Menu
    Facebook X (Twitter) Instagram
    KSA News TodayKSA News Today
    Facebook X (Twitter) Instagram
    • KSA
    • Business
    • Technology
    • Sports
    • Lifestyle
    KSA News TodayKSA News Today
    • KSA
    • Business
    • Technology
    • Sports
    • Lifestyle
    • Contact us
    Technology

    Google could invest up to $40 billion in Anthropic AI

    Editorial TeamBy Editorial TeamApril 28, 2026
    Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    According to a representative for Anthropic, Google recently committed $10 billion to the AI company at a $350 billion valuation with up to $30 billion more contingent on performance targets.

    The representative told Mobile World Live the investment builds upon its existing partnership, which includes a recent expansion of Anthropic’s use of Google’s TPU chips and cloud services.

    The arrangement with Google and Broadcom includes 5-gigawatts of capacity coming online starting in 2027 along with the opportunity for multiple additional gigawatts going forward to support the continued growth of Anthropic’s Claude models.

    The latest Google investment came a few days after Amazon pledged $5 billion to Anthropic, also at the $350 billion valuation, with an option for $20 billion more. In February, it raised $30 billion from a group of backers.

    Google has been a strategic partner and minority investor in Anthropic for several years.

    Several news sites report Anthropic is planning to go public over the coming months

    Bloomberg reported the fundraising surge is largely driven by Claude Code, an AI agent which speeds the process of writing computer software.

    Despite the partnership, the two companies remain direct rivals in the race to build and deploy AI models and infrastructure.

    Source: Mobile World Live

    Image Credit: Anthropic


    Source: Tahawul Tech

    Previous ArticleDubai firm rolls out ‘work from local cafe’ policy to support small businesses
    Next Article Etavopivat is the first in a new class of drugs to successfully meet both co-primary end-points in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

    Related Posts

    e& to revert to original Etisalat branding

    October 7, 2026

    Omidia conducts research on IoT deployments

    October 7, 2026

    PNY advances AI factories for enterprise deployment

    October 7, 2026
    Latest Posts

    Louvre Abu Dhabi appoints new director as museum enters next phase of growth

    World Bank forecast Saudi economy to rebound with 7.9% growth in 2027

    e& to revert to original Etisalat branding

    UAE strongly condemns Houthi’s continued targeting of civilian assets, Saudi ships

    Latest News

    e& to revert to original Etisalat branding

    October 7, 2026

    Omidia conducts research on IoT deployments

    October 7, 2026

    PNY advances AI factories for enterprise deployment

    October 7, 2026
    Facebook X (Twitter) Instagram Pinterest
    • KSA
    • Business
    • Technology
    • Sports
    • Lifestyle
    • Contact us
    2026. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.